54 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
and Enforceability
No Conflict; Required Filings and Consents
Compliance With Laws
Permits
Litigation
Real Property; Personal Property
Assigned Contracts …
Organization, Good Standing and Other Matters
Authority and Enforceability
No Conflict: Required Filings and Consents
Financing
Solvency
Litigation
8-K
EX-99.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
release constitutes forward-looking information within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act
8-K
IMPLQ
Impel Pharmaceuticals Inc
18 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:31am
of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words
8-K
IMPLQ
Impel Pharmaceuticals Inc
16 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
Litigation Reform Act of 1995, including, but not limited to, the Company’s ability to successfully appeal the Delisting Notice and maintain its listing
424B5
wh7nu
5 Oct 23
Prospectus supplement for primary offering
5:19pm
8-K
jqd382a4of
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.1
2jr8w
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
ykw01u8yu8nkx
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
mlcu o4vg
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
c5xx6au8 zk04x
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
NT 10-Q
b23u7
15 Aug 23
Notice of late quarterly filing
4:29pm
8-K
EX-99.1
7dviva8u
12 May 23
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
8:03am
8-K
EX-99.1
jwx4h6v
14 Nov 22
Impel PHARMACEUTICALS Announces THIRD Quarter 2022 Financial Results and Provides CORPORATE Update
7:55am
8-K
EX-99.1
iq3k1n9a
15 Aug 22
Impel PHARMACEUTICALS Announces SECOND Quarter 2022 Financial Results and Provides CORPORATE Update
8:06am